Key Highlights
- LFCR shares surged 55.24% to $6.52 at Monday's close on September 28, 2026, while the S&P 500 fell 0.77%.
- Lifecore agreed to be acquired by Webster Equity Partners for $6.28 per share in cash plus a contingent value right.
- The CVRs provide up to $160 million in aggregate cash payments tied to 2028 to 2030 performance milestones.
- The agreement includes a 30-day go-shop period, and closing is expected at the end of the fourth quarter of 2026.
Lifecore Biomedical (NASDAQ:LFCR) was among the gainers in US markets on Monday, September 28, 2026, closing the session up 55.24% at $6.52. The company announced a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million.
Latest Developments
Lifecore Biomedical announced on September 28, 2026 that it had entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming full achievement of certain performance milestones. Common stockholders will receive $6.28 per share in cash at closing, plus one non-tradable contingent value right per share.
The CVRs provide for up to $160 million in aggregate cash payments tied to Revenue milestones for 2028 and 2029 and an EBITDA milestone for 2030. The agreement includes a 30-day go-shop period, and the company's common stock will be Delisted from Nasdaq at closing.
Financial and Business Position
Lifecore is a contract development and Manufacturing organization serving the pharmaceutical and biotechnology industries, with a Franchise anchored in sterile injectable products and hyaluronic-acid-based materials. It expects to keep its headquarters in Chaska, Minnesota, and to operate under the Lifecore name after closing.
Businesses of that type have drawn steady interest from private-equity buyers, which have been active acquirers of specialized manufacturing and life-sciences-services assets. From here, the questions that matter are the ones common to any pending deal: the certainty and timing of closing, any required approvals, and whether competing interest or conditions could alter the outcome.
Stock-Market Context
US equities closed lower across the board on Monday. The S&P 500 fell 0.77% to 7,683.69, the Dow Jones Industrial Average lost 0.67% to 51,481.51 and the Nasdaq Composite dropped 0.92% to 26,820.38.
Bond yields kept climbing and the 10-year Treasury moved above 5.2%, a level last seen in 2007. Oil also firmed as US-Iran talks stalled, with WTI crude peaking near $96 a barrel intraday.
The $6.28 cash price represents a premium of about 49.5% to the closing price on the last full trading day before signing.
A Go-Shop Window on a CDMO Buyout
Lifecore closed Monday sharply higher on the day it agreed to be acquired by Webster Equity Partners. The go-shop period and the CVR milestones through 2030 are the terms that shape how the deal plays out before its expected year-end closing.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...